ASCT Viewpoint
Aug. 26, 2015

Immunotherapy may hold the key to attacking HPV-associated cancers
Although unprecedented improvements in our ability to diagnose and treat cancer have driven a decline in incidence and mortality rates for most cancers in the United States, notable exceptions to this trend include oropharyngeal, anal, and vulvar cancers in patients who harbor the human papillomavirus (HPV).More

ASCT Educational Webinars
ASCT Educational Webinars deliver high quality, affordable continuing education. ASCT members qualify for the 2016 Webinar discount. Order all six webinars (January-July 2016) for your lab for only $700!

Schedule 2016
Registration 2016 form

Cervical cancer and how the US is falling behind
In the United States, our health system is far from perfect, but we like to pride ourselves on delivering the highest quality and newest innovations in care. But one area where we lag behind even some African nations is in preventing cervical cancer — the most common gynecologic cancer worldwide. More

Health officials say they won't change HPV vaccine mandate
The Associated Press via Business Insider
State health officials say there are no plans to change a new requirement that middle school students in Rhode Island get the HPV vaccine even though some parents, and now some lawmakers, have expressed concerns. Children entering seventh grade in September must get the vaccine unless their parents seek an exemption for medical or religious reasons. Virginia and Washington, D.C., are the only other jurisdictions that require the vaccine to attend school. More

Chlamydia screens dropped after cervical cancer screening change
According to a 2013 fact sheet from the CDC, an estimated 2.8 million new chlamydia infections occur in the United States each year, and the highest prevalence of these infections is among females ages 15-24. Those numbers helped prompt researchers to investigate how a 2009 change in an American College of Obstetricians and Gynecologists recommendation on cervical cancer screening might affect the rate of chlamydia screening, given that the two tests had frequently been co-administered. More

Top takeaways from ASCO: HPV-associated head and neck cancer
De-intensified chemoradiation was efficacious in patients with low-risk, HPV-associated oropharyngeal squamous cell carcinoma, according to findings presented at the ASCO 2015 Annual Meeting. Barbara Ann Burtness, MD, professor of medicine (medical oncology), clinical research program leader, Head and Neck Cancers Program, and co-director, Developmental Therapeutics Research Program, Yale University, discussed the results with

The importance of vaccines during National Immunization Awareness Month
By Denise A. Valenti
August is National Immunization Awareness Month, with the last week of the month emphasizing the need to vaccinate infants and children. The campaign to increase awareness is an opportunity to remind parents of the importance of childhood immunizations as they prepare for their children to enter daycare or school. Over the years, vaccines have prevented the spread of many serious life-threatening diseases and have contributed to the eradication of others. More

A mouthwash rinse may predict throat cancer recurrence
The New York Times
A simple mouthwash rinse may be able to predict the dangerous recurrence of a kind of throat cancer that is rapidly increasing in heterosexual men, according to a new study. The cancers, which occur mostly among men who give women oral sex, are caused by human papilloma viruses. More